The effect of infusions with two analogues of prostaglandin F2alpha on corpus luteum function. 1976

A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist

With the exception of one volunteer given the prostaglandin during ovulation, a transient decline in progesterone during the infusion was observed with both compounds. It is likely that the marked declines that were observed cannot be attributed solely to diurnal variation. Although the menstrual cycle was shortened in some cases after the infusion, this was not well-correlated with the acute effects seen at the time of infusion. Under the experimental conditions of this study, neither analogue appeared to be luteolytic. However, infusions with both compounds did alter serum progesterone transiently. It seems likely that both compounds do exert a potent effect on the corpus luteum and may in fact be luteolytic when given at some other time in the menstrual cycle.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
September 1973, American journal of obstetrics and gynecology,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
October 1976, Biology of reproduction,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
January 1976, Prostaglandins,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
January 2000, Reviews of reproduction,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
January 1973, Advances in the biosciences,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
June 1986, Prostaglandins,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
October 1972, American journal of obstetrics and gynecology,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
April 1977, The Journal of endocrinology,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
September 2002, Prostaglandins & other lipid mediators,
A Leader, and M Bygdeman, and P Eneroth, and J N Martin, and N Wiqvist
April 2012, Biology of reproduction,
Copied contents to your clipboard!